Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor

Molecular Endocrinology

Volumn 22, Issue 1, 2008, Pages 156-166

  Dean, Thomas ^a   Vilardaga, Jean Pierre ^a   Potts Jr , John T ^a   Gardella, Thomas J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE RELATED PROTEIN RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING KINETICS; BONE METABOLISM; CALCIUM METABOLISM; CONTROLLED STUDY; EQUILIBRIUM CONSTANT; FLUORESCENCE RESONANCE ENERGY TRANSFER; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; LIGAND BINDING; NONHUMAN; PARATHYROID HORMONE RELEASE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; KINETICS; LUMINESCENT PROTEINS; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; PROTEIN BINDING; PROTEIN CONFORMATION; RECEPTORS, PARATHYROID HORMONE; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 38049086228     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2007-0274     Document Type: Article

References (42)

1. Tashjian Jr AH, Gagel RF 2006 Teriparatide [human PTH(1-34)]: 2.5 years of experience on the use and safety of the drug for the treatment of osteoporosis. J Bone Miner Res 21:354-365
2. Kronenberg HM 2006 PTHrP and skeletal development. Ann NY Acad Sci 1068:1-13
3. Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC 2005 Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115:2402-2411
4. Martin TJ 2005 Osteoblast-derived PTHrP is a physiological regulator of bone formation. J Clin Invest 115:2322-2324
5. Caulfield MP, McKee RL, Goldman ME, Duong LT, Fisher JE, Gay CT, DeHaven PA, Levy JJ, Roubini E, Nutt RF, Chorev M, Rosenblatt M 1990 The bovine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor binding domains of PTH and PTH-related protein are located within the 14-34 region. Endocrinology 127:83-87
6. Abou-Samra A-B, Uneno S, Jüppner H, Keutmann HT, Potts JT, Jr., Segre GV, Nussbaum SR 1989 Non-homologous sequences of parathyroid hormone and the parathyroid hormone related peptide bind to a common receptor on ROS 17/2.8 cells. Endocrinology 125:2215-2217
7. Hoare S, Gardella T, Usdin T 2001 Evaluating the signal transduction mechanism of the parathyroid hormone 1 receptor: effect of receptor-G-protein interaction on the ligand binding mechanism and receptor conformation. J Biol Chem 276:7741-7753
8. Castro M, Nikolaev VO, Palm D, Lohse MJ, Vilardaga JP 2005 Turn-on switch in parathyroid hormone receptor by a two-step parathyroid hormone binding mechanism. Proc Natl Acad Sci USA 102:16084-16089
9. Wittelsberger A, Corich M, Thomas BE, Lee BK, Barazza A, Czodrowski P, Mierke DF, Chorev M, Rosenblatt M 2006 The mid-region of parathyroid hormone (1-34) serves as a functional docking domain in receptor activation. Biochemistry 45:2027-2034
10. Shimizu N, Dean T, Tsang JC, Khatri A, Potts Jr JT, Gardella TJ 2005 Novel parathyroid hormone (PTH) antagonists that bind to the juxtamembrane portion of the PTH/PTH-related protein receptor. J Biol Chem 280:1797-1807
11. Gensure RC, Gardella TJ, Juppner H 2005 Parathyroid hormone and parathyroid hormone-related peptide, and their receptors. Biochem Biophys Res Commun 328:666-678
12. Horwitz MJ, Tedesco MB, Gundberg C, Garcia-Ocana A, Stewart AF 2003 Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 88:569-575
13. 2 vitamin D. J Bone Miner Res 20:1792-1803
14. Horwitz MJ, Tedesco MB, Sereika SM, Garcia-Ocana A, Bisello A, Hollis BW, Gundberg C, Stewart AF 2006 Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation study. Osteoporos Int 17:225-230
15. Hoare S, de Vries G, Usdin T 1999 Measurement of agonist and antagonist ligand binding parameters at the human parathyroid hormone type 1 receptor: evaluation of receptor states and modulation by guanine nucleotide. J Pharmacol Exp Ther 289:1323-1333
16. Dean T, Linglart A, Mahon MJ, Bastepe M, Juppner H, Potts Jr JT, Gardella TJ 2006 Mechanisms of ligand binding to the PTH/PTHrp receptor: selectivity of a modified PTH(1-15) radioligand for GαS-coupled receptor conformations. Mol Endocrinol 20:931-942
17. Hoare SR, Sullivan SK, Pahuja A, Ling N, Crowe PD, Grigoriadis DE 2003 Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands. Peptides 24:1881-1897
18. Kenakin T 2004 Principles: receptor theory in pharmacology. Trends Pharmacol Sci 25:186-192
19. De Lean A, Stadel J, Lefkowitz R 1980 A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J Biol Chem 255:7108-7117
20. Gardella TJ, Luck MD, Wilson AK, Keutmann HT, Nussbaum SR, Potts JT J, Kronenberg HM 1995 Parathyroid hormone (PTH)-PTH-related peptide hybrid peptides reveal functional interactions between the 1-14 and 15-34 domains of the ligand. J Biol Chem 270:6584-6588
21. Gardella T, Luck M, Jensen G, Usdin T, Jüppner H 1996 Converting parathyroid hormone-related peptide (PTHrP) into a potent PTH-2 receptor agonist. J Biol Chem 271:19888-19893
22. Behar V, Nakamoto C, Greenberg Z, Bisello A, Suva LJ, Rosenblatt M, Chorev M 1996 Histidine at position 5 is the specificity "switch" between two parathyroid hormone receptor subtypes. Endocrinology 137:4217-4224
23. Dean T, Khatri A, Potetinova Z, Willick G, Gardella TJ 2006 Role of amino acid side chains in region 17-31 of parathyroid hormone (PTH) in binding to the PTH receptor. J Biol Chem 281:32485-32495
24. Berlot CH 2002 A highly effective dominant negative αs construct containing mutations that affect distinct functions inhibits multiple Gs-coupled receptor signaling pathways. J Biol Chem 277:21080-21085
25. Vilardaga JP, Bunemann M, Krasel C, Castro M, Lohse MJ 2003 Measurement of the millisecond activation switch of G protein-coupled receptors in living cells. Nat Biotechnol 21:807-812
26. Rodbell M 1997 The complex regulation of receptor-coupled G-proteins. Adv Enzyme Regul 37:427-435
27. Heck M, Hofmann KP 2001 Maximal rate and nucleotide dependence of rhodopsin-catalyzed transducin activation: initial rate analysis based on a double displacement mechanism. J Biol Chem 276:10000-10009
28. Okazaki M, Nagai S, Dean T, Potts JJ, Gardella T 2007 Analysis of PTH-PTH receptor interaction mechanisms using a new, long-acting PTH(1-28) analog reveals selective binding to distinct PTH receptor conformations and biological consequences in vivo. J Bone Miner Res 22(Suppl 1):1190 (Abstract)
29. Nagai S, Okazaki M, Potts JJ, Juppner H, Gardella T 2007 Dissection of the mechanisms of PTH-mediated inhibition of sodium-dependent phosphate transport using a long-acting PTH(1-28) analog. J Bone Miner Res 22(Suppl 1):1189 (Abstract)
30. Tawfeek HA, Qian F, Abou-Samra AB 2002 Phosphorylation of the receptor for PTH and PTHrP is required for internalization and regulates receptor signaling. Mol Endocrinol 16:1-13
31. Castro M, Dicker F, Vilardaga JP, Krasel C, Bernhardt M, Lohse MJ 2002 Dual regulation of the parathyroid hormone (PTH)/PTH-related peptide receptor signaling by protein kinase C and β-arrestins. Endocrinology 143:3854-3865
32. Chauvin S, Bencsik M, Bambino T, Nissenson RA 2002 Parathyroid hormone receptor recycling: role of receptor dephosphorylation and β-arrestin. Mol Endocrinol 16:2720-2732
33. Bisello A, Chorev M, Rosenblatt M, Monticelli L, Mierke DF, Ferrari SL 2002 Selective ligand-induced stabilization of active and desensitized parathyroid hormone type 1 receptor conformations. J Biol Chem 277:38524-38530
34. Hilton JM, Dowton M, Houssami S, Sexton PM 2000 Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors. J Endocrinol 166:213-226
35. 2+- and guanyl nucleotide-dependent glucagon receptor cycle by use of permeabilized canine hepatocytes. J Biol Chem 267:25776-25785
36. Chen X, Macica CM, Dreyer BE, Hammond VE, Hens JR, Philbrick WM, Broadus AE 2006 Initial characterization of PTH-related protein gene-driven lacZ expression in the mouse. J Bone Miner Res 21:113-123
37. Shimizu M, Carter P, Khatri A, Potts JJ, Gardella T 2001 Enhanced activity in parathyroid hormone (1-14) and (1-11): novel peptides for probing the ligand-receptor interaction. Endocrinology 142:3068-3074
38. Shimizu N, Guo J, Gardella T 2001 Parathyroid hormone (1-14) and (1-11) analogs conformationally constrained by α-aminoisobutyric acid mediate full agonist responses via the juxtamembrane region of the PTH 1 receptor. J Biol Chem 276:49003-49012
39. Takasu H, Guo J, Bringhurst F 1999 Dual signaling and ligand selectivity of the human PTH/PTHrP receptor. J Bone Miner Res 14:11-20
40. Majeska RJ, Rodan SB, Rodan GA 1980 Parathyroid hormone-responsive clonal cell lines from rat osteosarcoma. Endocrinology 107:1494-1503
41. Yamamoto I, Shigeno C, Potts JTJ, Segre GV 1988 Characterization and agonist-induced down-regulation of parathyroid hormone receptors in clonal rat osteosarcoma cells. Endocrinology 122:1208-1217
42. Tawfeek H, Abou-Samra A 1999 Over-expression of β-arrestin-2 in LLCPK-1 cells stably expressing a green fluorescent protein-tagged PTH/PTHrP receptor increases internalization. J Bone Miner Res 14(Suppl):SU444 (Abstract)